- Q&M Dental (SGX:QC7)'s FY22 revenue met expectations but earnings were below. FY22 revenue and adjusted PATMI were 99%/90% of our forecast.
- The significant drop in COVID-19 related earnings and higher expenses in the development of AI-guided clinical support systems were the drag. Our adjusted PATMI excludes S$5.1mil of impairment of inventories (S$4.9mil) and plant and equipment (S$0.2mil) incurred in 4Q22.
- - Read this at SGinvestors.io -
- - Read this at SGinvestors.io -
The Positive
Number of clinics expanded.
- In FY22, Q&M Dental expanded the number of clinics by 16 (or 12%). Most of the new clinics were in Singapore, with 10 new clinics. Profitability from core dental operations tripled to S$3.4mil. This was due to a change in the accrual of staff bonuses from a lumpy 4Q to proportionate provisioning per quarter.
The Negative
Revenue per clinic declined.
- Read more at SGinvestors.io.
Above is the excerpt from report by Phillip Securities Research.
Clients of Phillip Capital may be the first to access the full report in PDF @ https://www.stocksbnb.com/.
Paul Chew Phillip Securities Research | https://www.stocksbnb.com/ 2023-03-10
Read also Phillip's most recent report:
2024-08-29 Q&M Dental Group - Organic Growth Returning.
Previous report by Phillip:
2024-03-18 Q&M Dental Group - Data-driven Treatments Can Commence.
Price targets by other brokers at Q&M Dental Target Prices.
Listing of research reports at Q&M Dental Analyst Reports.
Relevant links:
Q&M Dental Share Price History,
Q&M Dental Announcements,
Q&M Dental Dividends & Corporate Actions,
Q&M Dental News Articles
